Top compounds associated with response to IGFALS


Feature Type Standardized
Nominal ANOVA
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.025 0.4
mRNA Crizotinib CTRPv2 pan-cancer AAC 0.025 0.4
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.027 0.4
mRNA BRD-K99006945 CTRPv2 pan-cancer AAC -0.04 0.4
mRNA nakiterpiosin CTRPv2 pan-cancer AAC -0.025 0.4
mRNA BRD-K64610608 CTRPv2 pan-cancer AAC -0.029 0.4
mRNA pifithrin-alpha CTRPv2 pan-cancer AAC 0.028 0.4
mRNA tamatinib CTRPv2 pan-cancer AAC -0.028 0.4
mRNA BRD9647 CTRPv2 pan-cancer AAC 0.028 0.4
mRNA BCL-LZH-4 CTRPv2 pan-cancer AAC -0.04 0.4
Download CSV